The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242 · cited 2×
“…SUD than in those without SUD suggests that the theoretical formulation suggesting that patients may try to ‘‘self-medicate’’ negative symptoms (Khantzian, 1985, 1997; Siris, 1990) with substances may not be correct (Green et al., 1999; Buhler et al., 2002; Lammertink et al., 2001;…”
BackgroundThe self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538 · cited 1×
“…SUD than in those without SUD suggests that the theoretical formulation suggesting that patients may try to ‘‘self-medicate’’ negative symptoms (Khantzian, 1985, 1997; Siris, 1990) with substances may not be correct (Green et al., 1999; Buhler et al., 2002; Lammertink et al., 2001;…”
BackgroundGlutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · cited 2×
“Moreover, in the years subsequent to Wyatt’s article, reports of Olney and Farber (1995) and Sheitman and Lieberman (1998) have provided possible neurobiologic formulations that could account for the observations that continued symptomatology results in decline in long-term outcome in patients.”
BackgroundNeuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
The natural history and pathophysiology of treatment resistant schizophrenia
Sheitman, B. B., & Lieberman, J. A. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00052-6 · Cited by 140
Self-citation
Cited by
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617
Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.011 · Cited by 482
Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial
Keefe, R. S. E., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., Meltzer, H. Y., Green, M. F., Miller, D. D., Canive, J. M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301072 · Cited by 472
“This process resulted in nine test summary scores and five domain scores (after excluding facial emotion discrimination) that correspond to five of the seven domains in the MATRICS consensus battery (Green et al, 2004b).”
BackgroundMethodResultInfluentialSelf-citationLingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Gone to Pot – A Review of the Association between Cannabis and Psychosis
Radhakrishnan, R., Wilkinson, S. T., & D’Souza, D. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00054 · Cited by 310
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
Every-Palmer, S. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.012 · Cited by 299
Cannabis and psychosis/schizophrenia: human studies
D’Souza, D. C., Sewell, R. A., & Ranganathan, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0024-2 · Cited by 295
Ellgren, M., Spano, S. M., & Hurd, Y. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301127 · Cited by 287
Effects of cannabis use on outcomes of psychotic disorders: systematic review
Zammit, S., Moore, T. H. M., Lingford-Hughes, A., Barnes, T. R. E., Jones, P. B., Burke, M., & Lewis, G. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046375 · Cited by 275
Krause, M., Huhn, M., Schneider-Thoma, J., Bighelli, I., Gutsmiedl, K., & Leucht, S. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.1105 · Cited by 86
Gleason, K. A., Birnbaum, S. G., Shukla, A., & Ghose, S. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.122 · Cited by 77
Wisdom, J. P., Manuel, J. I., & Drake, R. E. (2011) · Psychiatric Services · doi:10.1176/appi.ps.62.9.1007 · Cited by 53
“Smaller but significant proportions have use disorders related to cocaine, amphetamines, barbiturates, and other drugs (7,8,11,15,16).”
BackgroundFirst Episode Psychosis, Substance Abuse and Prognosis: A Systematic Review
Archie, S., & Gyomorey, K. (2009) · Current Psychiatry Reviews · doi:10.2174/157340009788971074 · Cited by 20
Skryabin, V. Y., Vinnikova, M. A., Ezhkova, E. V., Titkov, M. S., & Bulatova, R. A. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1905589 · Cited by 17
Metadata
- Authors
- Green, A. I., Tohen, M. F., Hamer, R. M., Strakowski, S. M., Lieberman, J. A., Glick, I., & Scott Clark, W.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 66
- Issue
- 2-3
- Pages
- 125-135
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2133632803
- Cited by
- 195
- References
- 5
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.